The bank offers central mortgage institution loans, investment management services, and other related services for Swiss and German customers.
The notable investment portfolio of Zurich Kantonal Bank includes Apiax, Eyeware, Hylomorph, Nagi Bioscience, Picstars AG, Qnami, Resistell AG, TOLREMO therapeutics, Wingtra, xorlab, etc. As of February 2020, Zurich Kantonal Bank has made 77 investments. The bank’s most recent investment was in December, 2019, when Nagi Bioscience raised $1.8M.
Head of Business Customers Zurich West
Documentaries, videos and podcasts